首页> 美国卫生研究院文献>Asian Pacific Journal of Cancer Prevention : APJCP >Regulatory Effect of Resveratrol and Prednisolone on MDR1 Protein Expression in Acute Lymphoblastic Leukemia Cell Line (CCRF-CEM)
【2h】

Regulatory Effect of Resveratrol and Prednisolone on MDR1 Protein Expression in Acute Lymphoblastic Leukemia Cell Line (CCRF-CEM)

机译:白藜芦醇和泼尼松龙对急性淋巴细胞白血病细胞株(CCRF-CEM)MDR1蛋白表达的调节作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chemotherapy is the most widely recognized technique to regard leukemia and also different sorts of human tumors. In any case, tranquilize protection has stayed as the primary test against the adequacy of medications. Besides, having different unfriendly impacts, chemotherapy drugs are getting to be traded by characteristic modalities for growth treatment. In such manner, natural segments, for example, resveratrol and prednisolone have been recognized to sharpen the leukemic cells to modified cell demise through an arrangement of complex procedures. In this investigation, we have analyzed effect of 15, 50 and 100μM of resveratrol and 700μM of prednisolone on the human multidrug protection quality 1 (MDR1) as a notable marker for cell sedate protection. We assessed the impact of resveratrol and prednisolone on MDR1 protein expression in the CCRF-CEM cell line as an agent for intense lymphoblastic leukemia. The investigation was planned to clear up whether.
机译:化学疗法是治疗白血病以及各种人类肿瘤的最广泛认可的技术。在任何情况下,保持镇静作用一直是抵抗药物不足的主要考验。此外,由于化学疗法药物具有不同的不利影响,因此正被用于生长治疗的特征性方式进行交易。以这种方式,已经认识到天然片段,例如白藜芦醇和泼尼松龙通过一系列复杂程序将白血病细胞锐化为修饰的细胞死亡。在这项研究中,我们分析了15、50和100μM白藜芦醇以及700μM泼尼松龙对人多药保护质量1(MDR1)的影响,作为细胞沉着保护的重要标志。我们评估了白藜芦醇和泼尼松龙对CCRF-CEM细胞系中MDR1蛋白表达的影响,作为严重淋巴细胞白血病的一种药物。计划进行调查以明确是否。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号